Dipeptidyl Peptidase-4 Inhibitors and the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes in Taiwan: A Population-Based Cohort Study

To investigate the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on the risk of acute pancreatitis in patients with type 2 diabetes. This nationwide population-based cohort study used the diabetes patients dataset of Taiwan's National Health Research Insurance Research Database. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Yun-Ju, Hu, Hsiao-Yun, Chen, Hsin-Hua, Chou, Pesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985426/
https://www.ncbi.nlm.nih.gov/pubmed/26512613
http://dx.doi.org/10.1097/MD.0000000000001906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985426/
https://www.ncbi.nlm.nih.gov/pubmed/26512613
http://dx.doi.org/10.1097/MD.0000000000001906

Ejemplares similares